Table 1.
Treatment recommendations for pancreatic neuroendocrine tumors with von Hippel-Lindau disease[12]
Treatment recommendation | |
Prognostic criteria | |
Tumor size ≥ 3 cm | |
Mutation in exon 3 | |
Tumor doubling time ≤ 500 d | |
None of the criteria | Followed by CT/MRI every 2-3 yr |
1 criterion | Followed by CT/MRI every 6-12 mo |
2 or 3 criteria | Consider surgical intervention |
CT: Computed tomography; MRI: Magnetic resonance imaging.